Zim Laboratories Limited — Board Meeting, 12-11-2025: Outcome of Board Meeting
12-11-2025 | 06:57 pm
12-11-2025 | 06:57 pm
ZIM Laboratories' Board approved Q2/H1 FY26 consolidated financial results. The company reported a Q2 net loss of ₹0.42 Cr and H1 net loss of ₹2.30 Cr. Key operational moves include an agreement to sell unused land and the purchase of adjacent land.
No comments yet. Be the first to comment!
